article Open AccessTop 1% cited
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
International Journal of Obesity · 2011 · Vol. 36(6) · pp. 843–854
on behalf of the NN8022-1807 Investigators✉(University of Copenhagen)Arne Astrup(University of Copenhagen)Raffaele Carraro(Hospital Universitario de La Princesa)Nick Finer(Novo Nordisk (Denmark))A E Harper(Novo Nordisk (Denmark))Marie Kunešová(Glasgow Royal Infirmary)MEJ Lean(University of Eastern Finland)Leo Niskanen(University of Eastern Finland)Maria Rasmussen(Helsinki University Hospital)A Rissanen(Karolinska University Hospital)Stephan Rössner(Karolinska University Hospital)Markku J. Savolainen(Antwerp University Hospital)L. Van Gaal(Antwerp University Hospital)
Abstract
Liraglutide is well tolerated, sustains weight loss over 2 years and improves cardiovascular risk factors.
Pharmacology and Obesity TreatmentDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerLiraglutideTolerabilityWeight lossMedicineInternal medicineEndocrinologyPharmacologyObesityAdverse effectDiabetes mellitus
MeSH terms
LiraglutideAdolescentAdultAgedAnalysis of VarianceDouble-Blind MethodDrug Administration ScheduleEuropeExercise TherapyFemaleHumansMaleMiddle AgedObesityPrediabetic State
Funding
- Novo Nordisk
Citations
742
FWCI
40.67
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Cited by
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism · 2015 · 1,270 citations
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Metabolism · 2018 · 1,193 citations
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
International Journal of Obesity · 2016 · 506 citations
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
International Journal of Obesity · 2013 · 812 citations
References
A Multiple Comparison Procedure for Comparing Several Treatments with a Control
Journal of the American Statistical Association · 1955 · 5,871 citations
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
JAMA · 1993 · 27,890 citations
Definition of Metabolic Syndrome
Circulation · 2004 · 5,942 citations
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
New England Journal of Medicine · 2002 · 18,892 citations
Follow-up Report on the Diagnosis of Diabetes Mellitus
Diabetes Care · 2003 · 3,828 citations
National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health
Archives of Internal Medicine · 1991 · 1,144 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.